Fibrinolytic and antithrombotic therapy [[electronic resource] ] : theory, practice, and management / / Richard C. Becker, Frederick A. Spencer

• Record Nr.: UNINA9910777636203321
• Autore: Becker Richard C
• Pubbl/distr/stampa: Oxford ; ; New York, : Oxford University Press, 2006
• ISBN: 0-19-756195-0; 1-280-83783-7; 0-19-974906-X; 1-4294-0273-3
• Edizione: [2nd ed.]
• Descrizione fisica: 1 online resource (421 p.)
• Collana: Oxford scholarship online
• Altri autori (Persone): SpencerFredrick A., MD.
• Disciplina: 616.1/3506
• Soggetti: Thrombolytic therapy; Fibrinolytic agents; Thrombosis - Treatment
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Previously issued in print: 2006.
• Nota di bibliografia: Includes bibliographical references and index.
• Nota di contenuto: Historical perspectives in hemostasis, coagulation and fibrinolysis -- Vascular biology, thromboresistance and inflammation -- Atherosclerosis and arterial thrombosis -- Venous thromboembolism -- Cardiac chamber, aortic and valvular thromboembolism -- Fibrinolytic agents -- Aspirin -- Clopidogrel -- Platelet Glycoprotein IIb/IIIa receptor antagonists -- Aggrenox and cilostazol -- Novel platelet antagonists --; Combination pharmacotherapy -- Facilitated percutaneous coronary intervention -- Thrombin-directed therapy -- Factor Xa inhibitors -- Direct thrombin inhibitors -- Novel anticoagulants -- Acute coronary syndromes -- Peripheral vascular disease and stroke -- Valvular heart disease and atrial fibrillation -- Plaque-stabilizing therapies --; Venous thromboembolism prophylaxis -- Venous thromboembolism treatment -- Fundamentals and patient evaluation -- Platelet antagonists -- Anticoagulants -- Anticoagulation clinics and self-testing -- Platelet antagonists -- Anticoagulants -- Fibrinolytic agents.
• Sommario/riassunto: Thrombotic disorders of the circulatory system represent the leading cause of morbidity, mortality, and health care expenditure in the United ; States. The Second Edition of Fibrinolytic and Antithrombotic Therapy provides a practical, evidence-based approach to the managment of thrombotic disorders for all clinicians involved in the care of patients with these disorders. It provides not only vital conceptual information on fibrinolytic and antithrombotic therapy, but also the means to apply it to everyday decision making and patient care. Focusing on management guidelines and critical pathways, the text stresses practicality and usability. It will be a valuable resource for the wide range of clinicians involved in the care of patients with these disorders.